retatrutide ly3437943 phase 2 trial obesity nejm 2023 The biggest headline may not be the weight loss. It may be the word “biologic.” Lilly says it plans to submit retatrutide through a Biologics License Application, or BLA, in Q1 Retatrutide: A Triple Agonist Shaping

Your muscles need amino acids to repair and maintain themselves, and your overall intake is likely lower than it was before starting medication

Adverse events related to Tirzepatide

Metformin is not recommended when eGFR is consistently less than 30 mL/min/1.73 m 2 , and in LEADER, SUSTAIN 6 and PIONEER 6, some of those who were not taking metformin had lower eGFRs

First, beta arrestins and Gaq can both internalize the GLP- 1 receptor, and multiple ligands can affect internalization

In the clinical development programs and later in broad use after approval, no drug-drug interactions of DPP-4 inhibitors with other antidiabetic drugs or with common medications like antihypertensives, lipid lowering agents, diuretics or anticoagulants were observed (12, 19, 21, 22)